Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma
University of California, San Francisco
University of California, San Francisco
QuantumLeap Healthcare Collaborative
Centre Oscar Lambret
Massachusetts General Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Instituto do Cancer do Estado de São Paulo
The Netherlands Cancer Institute
Washington University School of Medicine
Herlev and Gentofte Hospital
Fox Chase Cancer Center
Heidelberg University
Brown University
OHSU Knight Cancer Institute
Brown University
Dong-A University Hospital
UNICANCER
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center